Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

Conditions:   Non Small Cell Lung Cancer;   Lung Cancer;   Nsclc;   NSCLC Stage II;   NSCLC, Stage III;   Unclassified Renal Cell Carcinoma;   Papillary Renal Cell Carcinoma;   Fumarate Hydratase Deficient Renal Cell Carcinoma;   Succinate Dehydrogenase Deficient Renal Cell Carcino ma;   Collecting Duct Renal Cell Carcinoma;   Chromophobe Renal Cell Carcinoma Interventions:   Radiation: Radiation Therapy;   Drug: Durvalumab Sponsor:   Memorial Sloan Kettering Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials